LPA and rheumatoid arthritis: It is conjectured that berberine may downregulate the MAPK pathway through regulating the function of LPA signaling and exert the anti-inflammatory and preventive effects on arteriosclerosis, thus improving RA and reducing the risk of RA-CVD.